9th Annual Biomarkers Congress
Medical Media Communications (MMC): Vascular Interventional Advances (VIVA)
Wynn Las Vegas
3131 Las Vegas Boulevard South Las Vegas, Nevada 89109
Las Vegas, Nevada
http://www.vivapvd.com/conference/
Vascular InterVentional Advances, VIVA, is celebrating 10 years of defining excellence in professional education in the field of vascular intervention and medicine. 

Over the past decade, VIVA has attracted a multispecialty audience and provided a broad and well-rounded educational experience for all participants involved in the care of patients with vascular disease.  Attendees include those from vascular surgery, interventional cardiology, vascular medicine, interventional radiology, neuroradiology, neurosurgery, and cardiothoracic surgery. 

Each year, our world-renowned domestic and international faculty challenge attendees to expand their horizons by critically evaluating evolving trends in the field.  VIVA participants learn from one another in an environment that truly supports camaraderie.  VIVA thrives on providing creative learning modalities and utilizing state-of-the-art technology, initiating this with the VIVA-developed Laptop Learningâ„¢ system, introduced at VIVA in 2003.  This system allows immediate and personal interaction with faculty and the ability to take an active role in live case discussions. 

In 2011, VIVA pushed the technology envelope and debuted a 3-dimensional learning experience, which was so popular that we’ve incorporated this technology into the daily general sessions for VIVA 12.  This cutting-edge technology along with intense and focused concurrent sessions, challenging and provocative live cases, and a broad spectrum of learning activities from a top-caliber faculty will make VIVA’s 10th anniversary a must-see educational event.

http://www.vivapvd.com/conference/

Schedule of Presentations:

Tuesday, October 9, 2012
07:55:00 General Session
08:00:00 Welcome to VIVA
08:05:00 When will we use Bare Stents and will new Stent Designs Provide Better Results and Value? Dennis W. Metzger
08:05:00 BIG PICTURE ISSUE - SFA TECHNOLOGY IN THE FUTURE: PERSPECTIVES ON THE FUTURE OF SFA ENDOVASCULAR TREATMENT - What Does it Look Like in 5 Years?
08:10:00 Will Endoluminal Bypass with Stent-Grafts Become the Default Therapy for Long Lesions and Extensive Disease – What’s Necessary to make this Happen? Richard Saxon
08:20:00 How Often will we use Drug-Eluting Stents – What Patients/Lesions will be the most Likely to Benefit? Michael D. Dake
08:25:00 Will Drug-Coated Balloons be the next Workhorse Technology and what are the Anticipated Practical Limitations?
08:35:00 Introduction to Live Cases in 3D
08:40:00 LIVE CASE DEMONSTRATIONS: Riverside Methodist Hospital Live Case Moderator: Tony Das, MDNew Presentation GARY SISKIN, Martin B Leon, BRUCE GRAY
09:30:00 Suboptimal Angioplasty Results: Options for Therapy
09:40:00 Will the Advantages of Percutaneous Extraluminal Bypass make it in Everyday Procedure in 5 Years Alan Lumsden
09:45:00 Are Bioresorbable Vascular Scaffolds Really Necessary – Will they get Approved, at What Cost, and When?
09:55:00 10th ANNIVERSARY KEYNOTE ADDRESS: Moral and Ethical Expectations of Leaders SRIKANT DATAR
10:10:00 REFRESHMENT BREAK
10:40:00 When My Go-To Therapy is Not the Right Choice - Position 1: When Not to Do Carotid Endarterectomy Daniel G. Clair
10:45:00 When My Go-To Therapy is Not the Right Choice - Position 2: When Carotid Artery Stent Placement is a Mistake
10:55:00 When My Go-To Therapy is Not the Right Choice - Position 3: When Best Medical Therapy is Not Appropriate Heather Gornik
11:00:00 Introduction to Live Cases in 3D
11:05:00 LIVE CASE DEMONSTRATIONS: Riverside Methodist Hospital and El Camino Hospital Suresh Vedantham, Jeffrey W. Olin, CHRISTOPHER KWOLEK, MARK BURKET, JAMES BENENATI, Joshua A. Beckman
12:00:00 LUNCH/SATELLITE SYMPOSIA
13:15:00 THORACIC AORTA
13:20:00 CURRENT PRACTICE - ASSESSING YOUR PATIENT: How I Analyze Acute Aortic Dissection and Symptomatic Aortic Intramural Hematoma: What’s Needed to Develop a Management Plan John A. Kaufman
13:30:00 Uncomplicated Type B Aortic Dissection – Do we Currently know who Benefits from a more Aggressive Approach and Should we be Parsing Patients into more Detailed Subgroups? EDWARD Y. WOO
13:35:00 Why I Do What I Do: A Decision Support Analysis for Chronic Type B Dissection with Aneurysm Formation: Open Surgery is the Best Treatment Because It's Definitive Thoralf Sundt
13:45:00 Why I Do What I Do: A Decision Support Analysis for Chronic Type B Dissection with Aneurysm Formation: TEVAR With or Without Adjunctive Endovascular Maneuvers is Less Risky and Just as Protective as Operative Repair
13:50:00 Why I Do What I Do: A Decision Support Analysis for Chronic Type B Dissection with Aneurysm Formation: The Spectrum of Adjunctive Endovascular Techniques to Promote False Lumen Thrombosis After TEVAR for Aortic Dissection – Why this is an Important Goal MANISH MEHTA
13:55:00 Introduction to Live Cases in 3D
14:00:00 LIVE CASE DEMONSTRATIONS: Riverside Methodist Hospital and El Camino Hospital Dierk Scheinert, Richard Saxon, ALAN LUMSDEN, Robert Lookstein, MANISH MEHTA
15:05:00 DEBATE: Snorkels, Chimneys, Periscopes, and Sandwiches are now Main Stream, Well-Established Techniques to Expand TEVAR/EVAR Applications - Position 1: Nonsense, These are Only Temporary Place Holders; Gimmicks that Should be Reserved only for Bail-Outs Because they are Doomed to Fail if Used in Inadequate Aortic Necks CHRISTOPHER KWOLEK
15:15:00 CARDIAC/STRUCTURAL HEART
15:15:00 DEBATE: Snorkels, Chimneys, Periscopes, and Sandwiches are now Main Stream, Well-Established Techniques to Expand TEVAR/EVAR Applications - Position 2: Without a Doubt, These are Positive Adjuncts that Allow us to Successfully Deliver Endovascular Treatment to More Extensive Aortic Disease – These Valuable Techniques are Here to Stay JASON T. LEE
15:20:00 REFRESHMENT BREAK
15:50:00 Minimally Invasive Open Approaches to Cardiac Valve Repair and Replacement: How and Why I Do It Nitish Badhwar
15:55:00 CURRENT PRACTICE - ASSESSING YOUR PATIENT: Selecting the Right Patients for TAVI Martin B. Leon
16:05:00 DEBATE: My Preferred Approach to TAVR is Best for Patients Because.....Position 1: Trans-Apical Delivery is Easier and has Better Outcomes with Less Stroke S. CHRIS MALAISRIE
16:10:00 DEBATE: My Preferred Approach to TAVR is Best for Patients Because.....Position 2: Trans-Femoral Introduction is Less Invasive, Simpler, and Has Less Morbidity RAJ MAKKAR
16:20:00 DEBATE: My Preferred Approach to TAVR is Best for Patients Because.....Position 3: Nontraditional Access Routes to the Aortic Valve Are Frequently the Best Choice
16:25:00 Introduction to Live Cases in 3D
16:30:00 LIVE CASE DEMONSTRATIONS: El Camino Hospital JOHN FRITZ ANGLE, JOHN LAIRD
17:40:00 DAY ONE CONCLUDES/SATELLITE SYMPOSIA
Wednesday, October 10, 2012
06:55:00 General Session
07:00:00 Satellite Symposia
08:05:00 Review of Tuesday's Live Cases KRISHNA ROCHA-SINGH
08:05:00 RENAL/HYPERTENSION/MESENTERIC
08:10:00 What’s the Future of Renal Artery Stenting – is it a Historical Relic or Will new Studies Dust it off and get it off the Shelf? MICHAEL R. JAFF
08:20:00 How do we get our Head Around Renal Denervation for Hypertension – How big is it, Who gets Treated, What can we Expect? MARK BURKET
08:25:00 Alternatives to RF Renal Nerve Ablation – Do Fast Followers Have Something Better to Offer? KRISHNA ROCHA-SINGH
08:35:00 SPECIAL FEATURE -- This Is How I Do It: My Strategy for Managing Renal and Visceral Aneurysms: Assessment, Planning, Techniques, Procedural Decisions JOHN FRITZ ANGLE
08:40:00 LIVE Award Presentation
08:45:00 Introduction to Live Cases in 3D
08:50:00 LIVE CASE DEMONSTRATIONS: Holy Name Hospital Jason Lee, R. CLEMENT DARLING, MICHAEL R. JAFF
09:55:00 VASCULAR DIAGNOSIS
10:00:00 CURRENT PRACTICE – ASSESSING YOUR PATIENT: Vascular Disease in Young Adults – What Should I be Thinking and More Importantly, Doing to Diagnose and Treat? Mark A. Creager
10:10:00 The Current Status of Bone Marrow-Derived Stem Cell Therapies for CLI: When is it Appropriate, How is it Done, and What Should we Expect? Jeffrey W. Olin
10:15:00 Molecular Imaging of Vascular Disease Now and in the Future: What Should we Expect and What Will it Contribute? Geoffrey D. Rubin
10:25:00 REFRESHMENT BREAK
10:55:00 LIVE CASE DEMONSTRATIONS: Holy Name Hospital and Hawaii Permanente Hospital Geoffrey D. Rubin, GUSTAVO ODERICH, Robert Lookstein, Daniel G. Clair, MARK BURKET, MICHAEL DAKE
10:55:00 Introduction to Live Cases in 3D
12:00:00 LUNCH/SATELLITE SYMPOSIA
13:20:00 LATE-BREAKING CLINICAL TRIALS Gary M. Ansel
14:05:00 Introduction to Live Cases in 3D
14:10:00 LIVE CASE DEMONSTRATIONS: Holy Name Hospital and Hawaii Permanente Hospital Dierk Scheinert, S. CHRIS MALAISRIE, John A. Kaufman
15:00:00 ILIAC & SFA
15:05:00 Why I Do What I Do: How the Recent Trials and my Experience Inform my Approach to Iliac Occlusive Disease: Stent-Grafts Versus Bare Stents Alan Matsumoto
15:15:00 SPECIAL FEATURE -- This Is How I Do It: My Go-To Techniques for Recanalization and Re-Entry During Treatment of Total Occlusions
15:20:00 Why I Do What I Do: When to Use Distal Embolic Protection and Lower Extremity Interventions SUBHASH BANERJEE
15:30:00 REFRESHMENT BREAK
15:55:00 CURRENT PRACTICE – ASSESSING YOUR PATIENT: How I use Imaging to Stratify Patients with Femoropopliteal Disease into Specific Treatment Algorithms Robert Lookstein
16:05:00 DEBATE: What Should we Currently Think of Atherectomy and De-Bulking? Position 1: Once Upon a Time, De-Bulking was a Promising Idea, but that Time is Gone
16:10:00 DEBATE: What Should we Currently Think of Atherectomy and De-Bulking? Position 2: “Not so fast,” Recent Studies Show that Atherectomy is Better than Most Endovascular Procedures and it Leaves Nothing Behind
16:20:00 Is There a Proven Value to Anti-Platelet Therapy After Endovascular PAD Procedures; if so, Does Everyone Need it or Only Certain Patients? BRUCE GRAY
16:25:00 Introduction to Live Cases in 3D
16:30:00 LIVE CASE DEMONSTRATIONS: Hawaii Permanente Hospital EDWARD Y. WOO, Richard Saxon, Jason Lee, David L. Dawson, Gary M. Ansel
17:30:00 DAY TWO CONCLUDES
19:00:00 VIVA 10th YEAR GALA RECEPTION
Thursday, October 11, 2012
06:55:00 General Session
07:00:00 Satellite Symposia
08:05:00 Review of Wednesday's Live Cases John Rundback
08:05:00 LINC FEATURED SYMPOSIUM: CRITICAL LIMB ISCHEMIA
08:10:00 CURRENT PRACTICE – ASSESSING YOUR PATIENT: My Diagnostic Evaluation of CLI and How it Influences my Treatment Strategy JAMES BENENATI
08:20:00 What Does the Angiosome Concept Practically add to my Procedure Planning and Technique for Treating CLI Patients – is a Custom-Tailored Approach, the Future? John Rundback
08:25:00 Is There a Hierarchical Clinical Benefit to Using Drug-Eluting Technologies Over POBA and Bare Stents for Tibial Disease; if so, in What Conditions and for What Lesions is it Obvious? DIERK SCHEINERT
08:35:00 Why I Do What I Do: My Approach to the Evaluation and Treatment Planning for Patients With a Lower Extremity Ulcer
08:40:00 ATLAS AWARD PRESENTATION
08:45:00 Introduction to Live Cases in 3D
08:50:00 LIVE CASE DEMONSTRATIONS: Park Hospital Leipzig, Germany ERIC VERHOEVEN, BRUCE GRAY, Matthew J. Eagleton, John Rundback
09:55:00 REFRESHMENT BREAK
10:20:00 CRITICAL LIMB ISCHEMIA/TIBIAL
10:25:00 The Endovascular Approach to Acute Limb Ischemia: When and How to Use Thrombectomy and Thrombolysis David L. Dawson
10:35:00 SPECIAL FEATURE – This is How I Do It: My Approaches to Alternative Lower Extremity Vascular Access: Popliteal, Tibial, and Pedal – When and How I Use Them
10:40:00 Step-by-Step Approach to Pedal Loop Interventions; How to Succeed
10:50:00 Introduction to Live Cases in 3D
10:55:00 LIVE CASE DEMONSTRATIONS: Park Hospital Leipzig, Germany THOMAS T. TSAI, Alan Matsumoto, MARK ESKANDARI, R. CLEMENT DARLING, Mark A. Creager, KENNETH ROSENFIELD
12:00:00 LUNCH/SATELLITE SYMPOSIA
13:20:00 LATE-BREAKING CLINICAL TRIALS MICHAEL R. JAFF
14:00:00 MISCELLANEOUS
14:05:00 In-Stent Re-Stenosis in the Visceral and Renal Arteries: Current Views on the Risk, Diagnosis, and Treatment Options THOMAS ZELLER
14:15:00 Contemporary Surgical Approaches to the Evaluation and Management of Chronic Mesenteric Ischemia Mark K. Eskandari
14:20:00 Introduction to Live Cases in 3D
14:25:00 LIVE CASE DEMONSTRATIONS: Presbyterian Heart Institute DIERK SCHEINERT, Stephen Kee, Matthew S. Johnson, BRUCE GRAY, SUBHASH BANERJEE, Peter Schneider
15:20:00 REFRESHMENT BREAK
15:45:00 CAROTID and STROKE
15:50:00 Where Do We Go After CREST? New Studies and Answers to Frequently Asked Questions in the Post-CREST Era Joshua A. Beckman
15:55:00 Carotid Disease Stratification: Is Plaque Composition an Important Factor to Currently Consider Before Selecting Therapy? JON MATSUMURA
16:05:00 CURRENT PRACTICE – ASSESSING YOUR PATIENT: My Decision Tree When Approaching a Symptomatic Patient with Carotid Artery Disease R. CLEMENT DARLING
16:10:00 New Strategies, Devices, and Techniques for Carotid Artery Stenting: Opportunities to Improve Outcomes or is This as Good as it Gets? JOHN LAIRD
16:20:00 Acute Stroke Intervention: Is There Something We’re Missing?
16:25:00 Intracranial Update: Current Status of Stents, Flow Diversion, Embolization, etc., to Treat Neurovascular Lesions Colin Derdeyn
16:30:00 Introduction to Live Cases in 3D
16:35:00 LIVE CASE DEMONSTRATIONS: Presbyterian Heart Institute GARY SISKIN, ZVONIMIR KRAJCER, Colin Derdeyn, Mark A. Creager
17:30:00 DAY THREE CONCLUDES/SATELLITE SYMPOSIA
Friday, October 12, 2012
07:55:00 General Session
08:00:00 Review of Thursday's Live Cases Peter Schneider
08:05:00 DEBATE: Endovascular AAA Treatment of Proximal Aortic Necks Less Than 10mm is Currently One of the Biggest Challenges for EVAR – What Works? Position 1: New Endograft Designs that Enhance Infra-Renal Sealing and Provide Supra-Renal Fixation Allow us to Confidently Manage Short Necks Down to 5mm Matthew J. Eagleton
08:05:00 ABDOMINAL AORTA
08:10:00 DEBATE: Endovascular AAA Treatment of Proximal Aortic Necks Less Than 10mm is Currently One of the Biggest Challenges for EVAR – What Works? Position 2: Stop Kidding Yourself, the Only Way to Securely Treat this Type of Anatomy is to use Fenestrated Devices in all Such Cases ERIC VERHOEVEN
08:20:00 SPECIAL FEATURE -- This Is How I Do It: My Complex EVAR Strategies for Graft Selection, Sizing, and Procedure Choreography, etc. MARK FARBER
08:25:00 In this Era, EVAR Should be Performed Percutaneously Whenever Possible and Here’s the Evidence Why it’s Best for Patients ZVONIMIR KRAJCER
08:35:00 DEBATE: Hybrid Procedures Versus Total Endovascular Management: What’s Possible for Total Arch and Thoracoabdominal Aortic Repair Now and in the Future? Position 1: The Hybrid Combination of Open and Endo Repair is Less Risky than Standard Surgery and for the Conceivable Future it is the Only Practical Approach Capable of Being Performed at Most Centers
08:40:00 DEBATE: Hybrid Procedures Versus Total Endovascular Management: What’s Possible for Total Arch and Thoracoabdominal Aortic Repair Now and in the Future? Position 2: “Hold on a Minute,” Hybrid Aortic Surgery is No Safer than Traditional Operative Repair; Total Endovascular Branch Solutions are Feasible and Ultimately, the Best Solution for Most Patients GUSTAVO ODERICH
08:50:00 THE WISDOM OF PERSPECTIVE -- The Three Most Important Challenges Facing EVAR Today
08:55:00 Cone Beam CT, Image Fusion, and Advanced Guidance in the Angio Suite: When I Most Appreciate the Benefits of What Leading-Edge Imaging Can Contribute
09:05:00 Ultrasound, CT, and MR Imaging Follow-up are all Possible, But Here’s my Surveillance Algorithm for When and How I Follow Patients Peter Schneider
09:10:00 Type II Endoleaks With an Enlarging Sac are Problematic – Here’s the Best Plan to Deal With Them Stephen Kee
09:15:00 What Does "Health Care Reform" Really Mean to the Practicing Vascular Specialist? KENNETH ROSENFIELD
09:25:00 How Will Hospital Systems Influence Purchasing of Devices in the Era of Cost Containment? SEAN LYDEN
09:35:00 The "Business" Case for Multispecialty Collaboration -- Why This Will be Critical for Survival of the Vascular Specialist MICHAEL R. JAFF
09:40:00 REFRESHMENT BREAK
09:55:00 VIVA 10th ANNIVERSARY LECTURE: "Houston, we Have a Problem" --Dealing With In-stent Restenosis Once it Happens....What Works and What Doesn't THOMAS T. TSAI
10:00:00 VENOUS/THROMBOEMBOLIC
10:05:00 CURRENT PRACTICE – ASSESSING YOUR PATIENT: What Supports my Decision to Intervene or Conservatively Treat Patients With Acute DVT Matthew S. Johnson
10:10:00 Why I Do What I Do: How Emerging Agents Have Changed My Approach to VTE Joshua A. Beckman
10:20:00 New Endovascular Procedures to Manage Life-Threatening Pulmonary Embolism: What Criteria are Used to Intervene and What are the Results? GARY ANSEL
10:30:00 Practice Trends: IVC filters – is the U.S. Completely Out of Step With the Rest of the World: What’s New and Where are we Headed?
10:35:00 What’s the Status of CCSVI and its Association with Multiple Sclerosis and Other Neurodegenerative Diseases: is it Getting Clearer or More Confusing? GARY SISKIN
10:45:00 Current Controversies and Recent Advances in the Endovascular Management of Varicose Veins
10:50:00 Experience with Stent-Grafts, Drug-Eluting Stents, and Drug Coated Balloons for Dialysis Access Lesions: What We’ve Learned Anne Roberts
11:00:00 10th Anniversary Rapid Fire Triumphs and Tragedies: Valuable Tips, Teaching Points, and Take-Home Messages From the Most Enlightening Cases of 2012 KENNETH ROSENFIELD, MANISH MEHTA, SEAN LYDEN, MICHAEL R. JAFF, Joshua A. Beckman, MICHAEL DAKE
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.